Frans Belpaire
Show
Sort by
-
Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4
-
Physiological aspects determining the pharmacokinetic properties of drugs in "The Practice of Medicinal Chemistry" (3rd Edition)
-
Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: A case series
-
Comparative kinetics of the uremic toxin p-cresol versus creatinine in rats with and without renal failure
-
The influence of endotoxemia on the pharmacokinetics and the electroencephalographic effect of propofol in the rat
-
Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat
-
Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects
-
Urinary excretion of the uraemic toxin p-cresol in the rat : contribution of glucuronidation to its metabolization
-
Medical problems related to recreational drug use at nocturnal dance parties
-
Influence of hypovolemia on the pharmacokinetics and electroencephalographic effect of gamma-hydroxybutyrate in the rat
-
Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock
-
Tolerance to gamma-hydroxybutyrate in the rat: pharmakinetic and pharmacodynamic aspects
-
Hypovolemia does not influence the pharmacokinetics and pharmacodynamics of gamma-hydroxybutyrate in the rat
-
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rabbit Part II: post-mortem infusion in trachea or stomach.
-
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rabbit Part I - experimental approach after in vivo intravenous infusion.
-
Het cytochroom-P450-enzymsysteem: Genetisch polymorfisme en geneesmiddelen-interacties.
-
Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update.
-
Relationship between gamma-hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat
-
Influence of naloxone on the increased sensitivity to propofol during hypovolemia in the rat
-
Development and validation of a high-performance liquid chromatographic method for the determination of gamma-hydroxybutyric acid in rat plasma.
-
Metoprolol-paroxetine interaction in human liver microsomes: Stereoselective aspects and prediction of the in vivo interaction.
-
Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of propofol in the rat
-
Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels? Experimental approach with rabbits
-
Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: In vitro studies using human liver microsomes.
-
Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
-
Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat
-
Relationship between etomidate plasma concentration and EEG effect in the rat
-
Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
-
In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol.
-
Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: In vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.
-
The influence of hemorrhagic shock on the pharmacokinetics and the analgesic effect of morphine in the rat
-
ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
-
Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol.
-
In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.
-
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
-
Diagnostic performance of the EMIT-tox (R) benzodiazepine immunoassay, FPIA serum benzodiazepine immunoassay, and radioreceptor assay in suspected acute poisoning.
-
Variability morphine disposition during long-term subcutaneous infusion in terminally ill cancer patients.
-
Pharmacokinetics and effects of drugs during shock and resuscitation
-
Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
-
Hepatotoxicity of N,N-dimethylformamide (DMF) in acute poisoning with the veterinary euthanasia drug T-61
-
Hepatotoxicity of N,N-dimethylformamide (DMF) in acute poisoning with the veterinary euthanasia drug T-61
-
The fate of xenobiotics in living organisms
-
Direct high-performance liquid chromatography determination of diastereomeric oxprenolol glucuronides.
-
High performance liquid chromatography determination of dextromethorphan and its metabolites in urine using solid-phase extraction.
-
Cytochrome P450: Genetic polymorphism and drug interactions.
-
Pharmacokinetics and electroencephalographic effects of etomidate in the rat
-
Severe diltiazem poisoning with intestinal pseudo-obstruction: case report and toxicological data
-
Stereoselective pharmacokinetics of oxprenolol and its glucoronides
-
Influence of endotoxin on the enantioselective disposition of drugs in different species
-
Determination of dextromethorphan and its metabolites in urine by high-performance liquid chromatography using solid-phase extraction